Aclaris Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Aclaris Therapeutics (ACRS) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Aclaris Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aclaris Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Aclaris Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $1.1M | 363k | 3.01 |
| 2025-09-30 | $200k | 105k | 1.90 |
| 2025-06-30 | $218k | 153k | 1.42 |
| 2025-03-31 | $113k | 74k | 1.53 |
| 2024-12-31 | $172k | 70k | 2.48 |
| 2024-09-30 | $37k | 32k | 1.15 |
| 2024-06-30 | $37k | 34k | 1.10 |
| 2024-03-31 | $87k | 70k | 1.24 |
| 2023-12-31 | $21k | 20k | 1.05 |
| 2023-09-30 | $354k | 52k | 6.86 |
| 2023-06-30 | $29k | 2.8k | 10.37 |
| 2023-03-31 | $16k | 2.0k | 8.09 |
| 2022-12-31 | $38k | 2.4k | 15.75 |
| 2022-09-30 | $43k | 2.9k | 15.05 |
| 2022-06-30 | $34k | 2.4k | 14.13 |
| 2022-03-31 | $33k | 1.7k | 19.23 |
| 2021-12-31 | $672k | 46k | 14.55 |
| 2021-09-30 | $30k | 1.7k | 18.18 |
| 2021-06-30 | $199k | 11k | 17.61 |
| 2021-03-31 | $373k | 15k | 25.24 |
| 2020-12-31 | $8.0k | 1.3k | 6.13 |
| 2020-09-30 | $13k | 5.0k | 2.59 |
| 2020-06-30 | $1.0k | 547 | 1.83 |
| 2020-03-31 | $20k | 19k | 1.05 |
| 2019-12-31 | $71k | 38k | 1.88 |
| 2019-09-30 | $10k | 9.1k | 1.10 |
| 2019-06-30 | $2.2M | 1.0M | 2.19 |
| 2019-03-31 | $4.1M | 684k | 5.99 |
| 2018-12-31 | $0 | 1.3M | 0.00 |
| 2018-09-30 | $0 | 19 | 0.00 |
| 2018-06-30 | $0 | 19 | 0.00 |
| 2018-03-31 | $43k | 2.4k | 17.51 |
| 2017-12-31 | $66k | 2.7k | 24.53 |
| 2017-09-30 | $156k | 6.1k | 25.81 |
| 2017-06-30 | $90k | 3.3k | 27.34 |
| 2017-03-31 | $134k | 4.5k | 29.92 |
| 2016-12-31 | $75k | 2.8k | 26.98 |
| 2016-09-30 | $56k | 2.2k | 25.53 |
| 2016-06-30 | $0 | 941 | 0.00 |
| 2016-03-31 | $0 | 633 | 0.00 |
| 2015-12-31 | $2.4k | 109 | 22.22 |